MENU
ADXN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Addex Therapeutics (ADXN) Ownership - Who owns Addex Therapeutics?
Profile
Industry
N/A
Address
Chemin des Aulx 12
Phone
+41 228841555
Employees
24
Web
https://www.addextherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
8.61M
P/E Ratio
N/A
Total Cash
3.35M
Projected Growth
N/A
Total Debt
43.77K
Revenue
556.05K
Risk (Beta)
1.66
Dividend Yield
N/A
Total Cash/Share
3.14
Total Debt/Equity
N/A
Revenue/Share
0.77 USD as % of share price
Fundamentals
ADXN
Capitalization
8.62M
P/E Ratio
N/A
Risk (Beta)
1.66
Dividend Yield
N/A
Total Cash
3.35M
Total Cash/Share
3.14
Total Debt
43.8K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.77%
Revenue
556K
ROE
N/A
Book Value
11.1M
P/B Ratio
0.70
Cash Flow
N/A
Earnings
6
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1.84M
Current Ratio
4.59
Current Revenue Per Employee
2340.74
Dividends Per Share - Security
N/A
EBITDA
-12.19M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
59.05
Shares Held By Institutions
13.6K
Shares Outstanding - Current
1.07M
Total Liabilities
1.11M
Total Volume MTD
N/A
Value
1
Gain YTD
13.857
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
Chemin des Aulx 12
Phone
+41 228841555
Employees
24
Web
https://www.addextherapeutics.com